NEWS & EVENTS
List
Icon
-
Taiwan FDA granted Market License of Irinotecan Injection 20mg/mL "GBC"MORE > -
GBC’s Specialty Oncology Injectable Generic Drugs Authorized Europe, Commercially Supply will Credit Increased Revenue in 2023-24MORE > -
Taiwan FDA granted Market License of Docetaxel Injection 20mg/mL "GBC"MORE > -
Zhunan Site Dedicated Peptide Synthesis Octreotide API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE > -
INTERPHEX Osaka (Part of INTERPHEX Week Osaka) 03/09/2022-03/11/2022 I Osaka, JapanMORE > -
Zhunan Site API Plant has been approved by Taiwan FDA PIC/S GMP Follow-up InspectionMORE >